Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Neoplasms 1Uterine Cervical Dysplasia 1Pain, Postoperative 1Ovarian Neoplasms 1Malignant Neoplasms of Female Genital Organs 1Leiomyoma 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Megestrol Acetate 7Medroxyprogesterone Acetate 4Progestins 3Metformin 3Tirzepatide 2Progesterone 2Letrozole 2Hysteroscopy 2Blood Specimen Collection 2Biopsy 2Atorvastatin 2semaglutide 1ricin A-GnRH conjugate 1exemestane 1estradiol, norethindrone drug combination 1Tamoxifen 1Surveys and Questionnaires 1Sampling Studies 1Rosuvastatin Calcium 1Restraint, Physical 1Resistance Training 1Pterocarpus marsupium 1Pharmacogenomic Variants 1Observation 1Nutrition Assessment 1Magnetic Resonance Spectroscopy 1Levonorgestrel 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Intrauterine Devices 1Immunohistochemistry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Hyperplasia × Bupivacaine × Gynecologic × Clear all
NCT05763667 2025-04-24

Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer

Tufts Medical Center

Phase 3 Completed
15 enrolled
Gynecologic

Endometrial Hyperplasia, Pain, Postoperative, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡